Yasuo Nakagishi - Concepedia

Author

Yasuo Nakagishi

Also Known As

Frank Weller-Heinemann, Thomas Stock, Y. Nakagishi, YASUO NAKAGISHI, Yasuo NAKAGISHI, Yasuo Nakagishi, on behalf of PRINTO and Eurofever Project

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Kobe Children's Hospital Kanazawa University Tokyo Medical and Dental University Yokohama City University Kagoshima University

About

Yasuo Nakagishi is an author at Kobe Children's Hospital specializing in immunology, medicine, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	671
2	Immunology	11	11	644
3	Pathology	9	9	500
4	Allergy	1	1	129
5	Obstetrics	1	1	27

Yasuo Nakagishi

Publications

Citations

H-Index

Page 1

	Year	Citations
Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis Masaki Shimizu, Yasuo Nakagishi, Natsumi Inoue, Clinical Immunology InflammationRheumatologyCytokineAutoimmune DiseaseImmunology	2015	167
Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles Masaki Shimizu, Yasuo Nakagishi, Akihiro Yachie Cytokine InflammationRheumatologyRheumatoid DisorderAllergyAutoimmune Disease	2012	129
Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The diagnostic significance of interleukin-18 and interleukin-6 Masaki Shimizu, Yasuo Nakagishi, Kazuko Kasai, Cytokine InflammationRheumatologyClinical SymptomsAutoimmune DiseaseImmunology	2012	127
Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome Mao Mizuta, Masaki Shimizu, Natsumi Inoue, Cytokine InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseRheumatic Diseases	2019	52
Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis Masaki Shimizu, Mao Mizuta, Nami Okamoto, Pediatric Rheumatology	2020	46
Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease Mao Mizuta, Masaki Shimizu, Natsumi Inoue, Modern Rheumatology	2016	45
Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis Naoto Sakumura, Masaki Shimizu, Mao Mizuta, Cytokine InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseMacrophage Activation	2018	42
Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease Tadamori Takahara, Masaki Shimizu, Yasuo Nakagishi, Rheumatology International InflammationRheumatologySerum Il-18Rheumatoid DisorderAutoimmune Disease	2014	37
Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ) Junko Yasumura, Masato Yashiro, Nami Okamoto, Pediatric Rheumatology	2019	37
Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children Mao Mizuta, Masaki Shimizu, Hitoshi Irabu, Lara D. Veeken	2020	34

Page 1